Christopher Lai
Directeur Général chez METiS Therapeutics, Inc.
Profil
Christopher Lai had founded two companies, AquaFresco, Inc. in 2015 and Metis Pharmaceuticals in 2019, where he held the title of Chief Technology Officer and General Manager & Executive Director respectively.
Dr. Lai is also the founder of METiS Therapeutics, Inc.
Postes actifs de Christopher Lai
| Sociétés | Poste | Début |
|---|---|---|
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology METiS Therapeutics, Inc. is a discovery technology and therapeutics company that aims to develop best-in-class drug assets across various therapeutic areas. The company is based in Cambridge, MA and has subsidiaries in the United States and China. Joining the team offers an exciting career in therapeutics for AI drug discovery. METiS Therapeutics was founded by Christopher Lai and Wenshou Wang, with Christopher Lai serving as the CEO since incorporation. | Directeur Général | - |
Metis Pharmaceuticals
 Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of METiS Therapeutics, Inc., Metis Pharmaceuticals is a Chinese company that focuses on independent innovation and research and development capabilities in the pharmaceutical industry. The company is based in Hangzhou, China. The company aims to accelerate the pace of innovation and promote high-quality industry development. Dishita Pharmaceuticals, the parent company, supports Metis Pharmaceuticals in developing more effective treatment drugs for patients. It was founded in 2019 by Christopher Lai, who has been the CEO since then. | Fondateur | 01/01/2019 |
Anciens postes connus de Christopher Lai
| Sociétés | Poste | Fin |
|---|---|---|
AquaFresco, Inc.
 AquaFresco, Inc. Industrial MachineryProducer Manufacturing AquaFresco, Inc. provides wastewater recycle system services. The firm serves in the area of hotels, commercial laundry facilities, car-wash, industrial cleaning, and other wastewater treatment process markets. The company was founded by Sasha Huang, Chris Lai and Alina Rwei in 2015 and is headquartered in Jamaica Plain, MA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing AquaFresco, Inc. provides wastewater recycle system services. The firm serves in the area of hotels, commercial laundry facilities, car-wash, industrial cleaning, and other wastewater treatment process markets. The company was founded by Sasha Huang, Chris Lai and Alina Rwei in 2015 and is headquartered in Jamaica Plain, MA. | Producer Manufacturing |
Metis Pharmaceuticals
Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of METiS Therapeutics, Inc., Metis Pharmaceuticals is a Chinese company that focuses on independent innovation and research and development capabilities in the pharmaceutical industry. The company is based in Hangzhou, China. The company aims to accelerate the pace of innovation and promote high-quality industry development. Dishita Pharmaceuticals, the parent company, supports Metis Pharmaceuticals in developing more effective treatment drugs for patients. It was founded in 2019 by Christopher Lai, who has been the CEO since then. | Health Technology |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology METiS Therapeutics, Inc. is a discovery technology and therapeutics company that aims to develop best-in-class drug assets across various therapeutic areas. The company is based in Cambridge, MA and has subsidiaries in the United States and China. Joining the team offers an exciting career in therapeutics for AI drug discovery. METiS Therapeutics was founded by Christopher Lai and Wenshou Wang, with Christopher Lai serving as the CEO since incorporation. | Health Technology |
